|
|
Volumn 2, Issue 2, 2001, Pages 157-173
|
|
Biotechnology in the development of new vaccines and diagnostic reagents against tuberculosis
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADJUVANT;
ANTIBODY;
ANTIGEN 85;
BACTERIAL ANTIGEN;
BCG VACCINE;
CFP 10;
ESAT 6;
HEAT SHOCK PROTEIN 60;
HEAT SHOCK PROTEIN 70;
REAGENT;
RECOMBINANT DNA;
SYNTHETIC PEPTIDE;
TUBERCULIN;
UNCLASSIFIED DRUG;
VACCINE;
ARTICLE;
BIOTECHNOLOGY;
CONTROLLED STUDY;
CROSS REACTION;
DRUG DELIVERY SYSTEM;
ENVIRONMENT;
EVALUATION;
GENE EXPRESSION;
GENE SEQUENCE;
HUMAN;
IMMUNOGENICITY;
IMMUNOLOGY;
MICROBIAL ATTENUATION;
MORTALITY;
MYCOBACTERIUM BOVIS;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
OPEN READING FRAME;
POPULATION;
T LYMPHOCYTE;
TUBERCULOSIS;
ANIMALS;
BACTERIAL VACCINES;
BIOTECHNOLOGY;
HUMANS;
INDICATORS AND REAGENTS;
MYCOBACTERIUM TUBERCULOSIS;
REAGENT KITS, DIAGNOSTIC;
TECHNOLOGY, PHARMACEUTICAL;
TUBERCULOSIS;
VACCINES, DNA;
BACTERIA (MICROORGANISMS);
CORYNEBACTERINEAE;
MYCOBACTERIUM;
MYCOBACTERIUM BOVIS BCG;
MYCOBACTERIUM TUBERCULOSIS;
|
|
EID: 0035016438
PISSN: 13892010
EISSN: None
Source Type: Journal
DOI: 10.2174/1389201013378707 Document Type: Article |
|
Times cited : (48)
|
|
References (120)
|
